Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Lactate Dehydrogenase to Carboxyhemoglobin Ratio As a Biomarker of Heme Release to Heme Processing Is Associated with Higher Tricuspid Regurgitant Jet Velocity and Early Death in Sickle Cell Disease

Annelies J. Van Vuren, MD, Laurel Mendelsohn, BS, Richard van Wijk, PhD, Caterina P. Minniti, MD, John Baird, MD, Gregory J Kato, MD, Eduard J. van Beers, MD PhD

Blood (2019) 134 (Supplement_1): 2274.

https://doi.org/10.1182/blood-2019-124048

Published: 2019

Journal Articles

Supervised Machine Learning Algorithms Using Patient Related Factors to Predict in-Hospital Mortality Following Acute Myeloid Leukemia Therapy

Nauman Saleem Siddiqui, MD, Andreas Klein, MD, Amandeep Godara, MD, Cindy Varga, MD BSc, Rachel J. Buchsbaum, MD, Michael C. Hughes, PhD

Blood (2019) 134 (Supplement_1): 3435.

https://doi.org/10.1182/blood-2019-128823

Published: 2019

Journal Articles

Hematologist Experiences and Perceptions of Outpatient Management of Adult Patients with Sickle Cell Disease

Jennifer Yui, MD, Farzana Sayani, MD, Marilyn Schapira, MD

Blood (2019) 134 (Supplement_1): 4710.

https://doi.org/10.1182/blood-2019-131611

Published: 2019

Journal Articles

Aspartate Beta-Hydroxylase (ASPH) As a Novel Therapeutic Target in Acute Myeloid Leukemia

Noa G. Holtzman, MD, Michael S. Lebowitz, PhD, Rima Koka, MD PhD, Maria R. Baer, MD, Kanam Malhotra, Steven A. Fuller, PhD, Amir Shahlaee, MD, Hossein A. Ghanbari, PhD, Soren M. Bentzen, PhD DMSc, Ashkan Emadi, MD PhD

Blood (2018) 132 (Supplement 1): 5273.

https://doi.org/10.1182/blood-2018-99-110897

Published: 2018

Journal Articles

Peripheral Blood Blast Clearance As an Independent Predictor of Clinical Response and Outcomes in Acute Myeloid Leukemia

Noa G. Holtzman, MD, Firas El Chaer, MD, Omer Ali, MD, Ameet Patel, MD, Maria R. Baer, MD, Vu H. Duong, MD, Edward A. Sausville, MD PhD, Arash Etemadi, MD PhD, Ashkan Emadi, MD PhD

Blood (2018) 132 (Supplement 1): 2684.

https://doi.org/10.1182/blood-2018-99-115512

Published: 2018

Journal Articles

Sickle Cell Patient Education: Assessment of the Emmi Electronic Teaching Module

Lewis L Hsu, MD PhD, Jennie Y Law, MD, Tammie Tam, BS

Blood (2017) 130 (Supplement 1): 5582.

https://doi.org/10.1182/blood.V130.Suppl_1.5582.5582

Published: 2017

Journal Articles

Androgen Receptor Overexpression in Mantle Cell Lymphoma: Potential Novel Therapeutic Implications

Paul S Martin, MD, Elahe Mostaghel, MD PhD, Stephen Mongovin, Shani L. Frayo, Ailin Zhang, Kerstin Lara Edlefsen, MD, Oliver W Press, MD PhD, Ajay K. Gopal, MD

Blood (2016) 128 (22): 3014.

https://doi.org/10.1182/blood.V128.22.3014.3014

Published: 2016

Journal Articles

Cost-Effectiveness of Blood Transfusions Versus Observation for Silent Cerebral Infarcts from the Silent Cerebral Infarct Trial

James C. Gay, MD MMHC, Timothy McCavit, MD, David Bundy, MD MPH, Allison King, MD MPH, PhD, Harold P. Lehman, MD, John J. Strouse, MD PhD, James F. Casella, MD, Mark J. Rodeghier, PhD, Michael DeBaun, MD

Blood (2016) 128 (22): 3655.

https://doi.org/10.1182/blood.V128.22.3655.3655

Published: 2016

Journal Articles

Distribution of Cytogenetic Abnormalities in African American Multiple Myeloma Patients May be Unique for Different Geographic Regions

Manisha Bhutani, MD, Preeya Patel, BS, Myra M Robinson, Rupali Bose, Kyle Madden, BS, Jill Eddy, Candice G Roth, RN, MSN, James Symanowski, Tammy Cogdill, NP, Jordan Robinson, PA-C, Belinda R Avalos, MD, Edward A. Copelan, MD, Saad Z Usmani, MD FACP

Blood (2015) 126 (23): 5337.

https://doi.org/10.1182/blood.V126.23.5337.5337

Published: 2015

Journal Articles

Outcome Comparison of Lymphoma and Myeloma Patients after Autologous Stem Cell Transplantation (ASCT) with Peripheral Blood Stem Cell Mobilization Between Plerixafor (P) Mobilized in Poor Mobilizer Patients and Non-Plerixafor Mobilized Patients

Shahbaz A. Malik, MD, Saul Yanovich, MD, Aaron P. Rapoport, MD, Ashraf Z Badros, MD, Nancy M. Hardy, MD, Mehmet H. Kocoglu, MD, Alison Duffy, Kathleen Ruehle, Jennifer Nishioka, Olga Goloubeva, PhD, Jean Yared, MD

Blood (2015) 126 (23): 5507.

https://doi.org/10.1182/blood.V126.23.5507.5507

Published: 2015

Journal Articles

Characteristics of Primary Thrombotic Microangiopathy in Patients with and without Human Immunodeficiency Virus: Thirteen Year Experience at the University of Maryland

Victoria Giffi, MD, Mya S. Thein, MD, Ann Zimrin, MD

Blood (2014) 124 (21): 4203.

https://doi.org/10.1182/blood.V124.21.4203.4203

Published: 2014

Journal Articles

A Novel Multi-Gene Array Allows Relapse Risk Stratification in Acute Myeloid Leukemia Patients Undergoing Stem Cell Transplantation

Meghali Goswami, BS, Katherine S. McGowan, Kit Lu, MD, Natasha A Jain, MD, Julián Candia, PhD, Nancy F. Hensel, Jingrong Tang, MDPhD, Katherine R. Calvo, MD, PhD, Minoo Battiwalla, MDMS, Austin John Barrett, MDFRCP,FRCPath, Christopher S. Hourigan, MDPhD

Blood (2014) 124 (21): 667.

https://doi.org/10.1182/blood.V124.21.667.667

Published: 2014

Journal Articles

Clinical Benefit Of Anticoagulation In Treatment Of Catheter-Related Deep Vein Thrombosis In Patients With Acute Leukemia

Briana Short, MD, Nora Oliver, MD, Mya S Thein, MD, Vu H. Duong, MD, Michael L. Tidwell, C.R.N.P., Edward A. Sausville, MD, PhD, Farin Kamangar, MD, PhD, Maria R. Baer, MD, Ashkan Emadi, M.D., Ph.D.

Blood (2013) 122 (21): 2389.

https://doi.org/10.1182/blood.V122.21.2389.2389

Published: 2013

Journal Articles

Validation Of a Brief Arsenic Trioxide (ATO)-Based Consolidation Chemotherapy In The Upfront Management Of Acute Promyelocytic Leukemia (APL): Less Anthracycline Exposure and Faster Completion Of Consolidation Therapy With Equivalent Survival

Mindy Leech, PharmD, Moshe Stewart, Xu Zhang, PhD, Asad Bashey, MD, PhD, H. Kent Holland, MD, Scott R. Solomon, MD, Hetty E Carraway, MD, MBA, B. Douglas Smith, MD, Lawrence E. Morris, MD, Steven D. Gore, MD, Amer M. Zeidan, MD

Blood (2013) 122 (21): 3963.

https://doi.org/10.1182/blood.V122.21.3963.3963

Published: 2013

Journal Articles

Analysis of the Coding Genome of Follicular Lymphoma Identifies Multiple Novel Recurrently Mutated Genes

Sami Malek, MD, Yifeng Li, MD, Hongxiu Li, PhD, Peter Ouillette, Sian Jones, PhD, Heather Fox, Kathryn Jacobi, Kamlai saiya-Cork, Dale Bixby, MD PhD, Daniel Lebovic, MD, Kerby Shedden, PhD, Michael Sabel, MD, Lawrence Marentette, MD, Vincent Cimmino, MD, Alfred Chang, MD, Mark S. Kaminski, MD

Blood (2012) 120 (21): 147.

https://doi.org/10.1182/blood.V120.21.147.147

Published: 2012

Journal Articles

Short Survival and High Rates of Transformation Prevail in Chronic Myelomonocytic Leukemia Despite Hypomethylating Agent Therapy.

Emily J. Vannorsdall, M.D., Vu H. Duong, M.D., Xinyi Ng, B.S., Dan P. Zandberg, M.D., Michael L. Tidwell, C.R.N.P., Amy J. Davidoff, M.S., Ph.D., Maria R. Baer, M.D.

Blood (2012) 120 (21): 2800.

https://doi.org/10.1182/blood.V120.21.2800.2800

Published: 2012

Journal Articles

Hospital-Acquired DVT/PE As “Never Events”: A Misguided Strategy for Performance Improvement in VTE Prevention.

Brandyn Daniel Lau, MPH, CPH, Elliott R Haut, MD, Bhunesh Maheshwari, MD, Aileen Almario, RN, MSN, Chepkorir Maritim, RN, Deborah Hobson, RN, Peggy S Kraus, PharmD, Kenneth Shermock, PharmD PhD, Howard Carolan, MPH, MBA, Michael B. Streiff, MD

Blood (2012) 120 (21): 3180.

https://doi.org/10.1182/blood.V120.21.3180.3180

Published: 2012

Journal Articles

Outpatient Visits, Hospitalizations and Emergency Department Visits Among Patients with Sickle Cell Disease On Medicaid: Trends in 14 USA States, 2006–2007.

Benjamin Ansa, MD, Tom Adamkiewicz, MD, MSCR, FRCP(C), Yvonne Fry-Johnson, MD, MSCR, Gregory Strayhorn, MD, PhD, Barbara Moore, George S Rust, MD, MPH

Blood (2012) 120 (21): 3181.

https://doi.org/10.1182/blood.V120.21.3181.3181

Published: 2012

Journal Articles

Prolonged Survival in Secondary CNS Lymphoma Following High Dose Thiotepa/Busulfan-Based Chemotherapy (HDTB) and Autologous Stem Cell Transplantation (ASCT): Single Institution Results From Calgary, Canada

Lesley E. Street, MD, FRCPC, Nizar J. Bahlis, MD, Karen Valentine, MD, PhD, Deirdre A. Jenkins, MD, FRCPC, Carolyn J Owen, MD, FRCPC, Mona Shafey, MD, FRCPC, Peter Duggan, MD, FRCPC, Douglas A. Stewart, MD, FRCPC

Blood (2012) 120 (21): 2003.

https://doi.org/10.1182/blood.V120.21.2003.2003

Published: 2012

Journal Articles

Lack of Response of Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) to Decitabine After Failure of Azacitidine

Bhavana Bhatnagar, DO, Dan P. Zandberg, M.D., Emily J. Vannorsdall, M.D., Alison P. Duffy, Pharm.D., Michael L. Tidwell, C.R.N.P., Yi Ning, Qing Chen, M.D., Maria R. Baer, M.D.

Blood (2012) 120 (21): 3858.

https://doi.org/10.1182/blood.V120.21.3858.3858

Published: 2012

NARROW

Lactate Dehydrogenase to Carboxyhemoglobin Ratio As a Biomarker of Heme Release to Heme Processing Is Associated with Higher Tricuspid Regurgitant Jet Velocity and Early Death in Sickle Cell Disease

Supervised Machine Learning Algorithms Using Patient Related Factors to Predict in-Hospital Mortality Following Acute Myeloid Leukemia Therapy

Hematologist Experiences and Perceptions of Outpatient Management of Adult Patients with Sickle Cell Disease

Aspartate Beta-Hydroxylase (ASPH) As a Novel Therapeutic Target in Acute Myeloid Leukemia

Peripheral Blood Blast Clearance As an Independent Predictor of Clinical Response and Outcomes in Acute Myeloid Leukemia

Sickle Cell Patient Education: Assessment of the Emmi Electronic Teaching Module

Androgen Receptor Overexpression in Mantle Cell Lymphoma: Potential Novel Therapeutic Implications

Cost-Effectiveness of Blood Transfusions Versus Observation for Silent Cerebral Infarcts from the Silent Cerebral Infarct Trial

Distribution of Cytogenetic Abnormalities in African American Multiple Myeloma Patients May be Unique for Different Geographic Regions

Outcome Comparison of Lymphoma and Myeloma Patients after Autologous Stem Cell Transplantation (ASCT) with Peripheral Blood Stem Cell Mobilization Between Plerixafor (P) Mobilized in Poor Mobilizer Patients and Non-Plerixafor Mobilized Patients

Characteristics of Primary Thrombotic Microangiopathy in Patients with and without Human Immunodeficiency Virus: Thirteen Year Experience at the University of Maryland

A Novel Multi-Gene Array Allows Relapse Risk Stratification in Acute Myeloid Leukemia Patients Undergoing Stem Cell Transplantation

Clinical Benefit Of Anticoagulation In Treatment Of Catheter-Related Deep Vein Thrombosis In Patients With Acute Leukemia

Validation Of a Brief Arsenic Trioxide (ATO)-Based Consolidation Chemotherapy In The Upfront Management Of Acute Promyelocytic Leukemia (APL): Less Anthracycline Exposure and Faster Completion Of Consolidation Therapy With Equivalent Survival

Analysis of the Coding Genome of Follicular Lymphoma Identifies Multiple Novel Recurrently Mutated Genes

Short Survival and High Rates of Transformation Prevail in Chronic Myelomonocytic Leukemia Despite Hypomethylating Agent Therapy.

Hospital-Acquired DVT/PE As “Never Events”: A Misguided Strategy for Performance Improvement in VTE Prevention.

Outpatient Visits, Hospitalizations and Emergency Department Visits Among Patients with Sickle Cell Disease On Medicaid: Trends in 14 USA States, 2006–2007.

Prolonged Survival in Secondary CNS Lymphoma Following High Dose Thiotepa/Busulfan-Based Chemotherapy (HDTB) and Autologous Stem Cell Transplantation (ASCT): Single Institution Results From Calgary, Canada

Lack of Response of Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) to Decitabine After Failure of Azacitidine

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only